We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+23.21%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1B
AUM Growth
+$154M
Cap. Flow
+$86.2M
Cap. Flow %
8.59%
Top 10 Hldgs %
45.9%
Holding
94
New
30
Increased
21
Reduced
13
Closed
27

Top Buys

Rank Stock Value
1
POST icon
Post Holdings
POST
+$25.4M
2
CMG icon
Chipotle Mexican Grill
CMG
+$23.3M
3
HBI
Hanesbrands
HBI
+$20.8M
4
UAA icon
Under Armour
UAA
+$20.2M
5
HOG icon
Harley-Davidson
HOG
+$18.7M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$22.4M
2
NOMD icon
Nomad Foods
NOMD
+$21.7M
3
INCY icon
Incyte
INCY
+$17M
4
ADMS
Adamas Pharmaceuticals
ADMS
+$15.9M
5
DKS icon
Dick's Sporting Goods
DKS
+$13.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.41%
2 Consumer Discretionary 28.7%
3 Consumer Staples 9.04%
4 Industrials 2.93%
5 Financials 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$149M 14.9%
560,000
-20,000
-3% -$5.2M
AVTX icon
2
Avalo Therapeutics
AVTX
$1.02B
$51.4M 5.12%
5,573
+17
+0.3% +$73.2K
HAIN icon
3
CALL
Hain Celestial
HAIN
$50.6M
$46.6M 4.65%
1,100,000
+200,000
+22% +$7.92M
VNDA icon
4
Vanda Pharmaceuticals
VNDA
$327M
$40.7M 4.06%
2,678,000
+1,146,000
+75% +$17M
UTHR icon
5
United Therapeutics
UTHR
$22.7B
$29.6M 2.95%
200,000
+50,000
+33% +$6.36M
ASRT
6
DELISTED
Assertio
ASRT
$29.4M 2.94%
60,967
-16,566
-21% -$6.44M
ENR icon
7
Energizer
ENR
$1.39B
$29.4M 2.93%
612,000
+88,000
+17% +$4.04M
HBI
8
DELISTED
Hanesbrands
HBI
$29.3M 2.92%
1,400,000
+976,000
+230% +$20.8M
CPB icon
9
Campbell Soup
CPB
$6.58B
$29.3M 2.92%
608,000
+312,000
+105% +$14.8M
PZZA icon
10
CALL
Papa John's
PZZA
$1.08B
$25.3M 2.52%
+450,000
New +$28M
POST icon
11
Post Holdings
POST
$3.94B
$24.7M 2.46%
+476,736
New +$25.4M
FRPT icon
12
Freshpet
FRPT
$2.78B
$24.5M 2.44%
1,292,000
-120,000
-8% -$2.09M
PLYA
13
DELISTED
Playa Hotels & Resorts
PLYA
$24M 2.39%
2,224,000
+596,000
+37% +$6.34M
CMG icon
14
Chipotle Mexican Grill
CMG
$44.2B
$22.5M 2.25%
+3,900,000
New +$23.3M
SBBP
15
DELISTED
Strongbridge Biopharma plc.
SBBP
$20.8M 2.07%
2,870,000
+1,175,400
+69% +$7.34M
UAA icon
16
Under Armour
UAA
$3.17B
$20.2M 2.01%
+1,400,000
New +$20.2M
HOG icon
17
Harley-Davidson
HOG
$2.8B
$19.5M 1.95%
+384,000
New +$18.7M
CAKE icon
18
Cheesecake Factory
CAKE
$4.26B
$19.3M 1.92%
400,000
+76,000
+23% +$3.45M
TLRD
19
DELISTED
Tailored Brands, Inc.
TLRD
$17M 1.7%
780,000
-152,000
-16% -$2.55M
ATRS
20
DELISTED
Antares Pharma, Inc.
ATRS
$15.1M 1.51%
7,600,000
+3,400,000
+81% +$7.4M
PCRX icon
21
Pacira BioSciences
PCRX
$1.01B
$15M 1.49%
328,000
+40,000
+14% +$1.59M
CPRI icon
22
Capri Holdings
CPRI
$1.88B
$14.9M 1.48%
+236,000
New +$12.9M
GSK icon
23
GSK
GSK
$104B
$14.6M 1.46%
+329,600
New +$15.2M
HZNP
24
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$14.6M 1.46%
1,000,000
+200,000
+25% +$2.81M
CVS icon
25
CVS Health
CVS
$137B
$14.5M 1.45%
+200,000
New +$14.5M
1
2 3 4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Armistice Capital held 94 positions worth $1B, up 18% from $849M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Armistice Capital deployed $86.2M of net new capital in Q4 2017, opening 30 new positions and adding to 21 existing holdings. Its largest new stake was Post Holdings: 476,736 shares worth $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Madrigal Pharmaceuticals, an estimated $8.68M trimmed.

  • Armistice Capital's largest Q4 2017 buy was Post Holdings: 476,736 shares worth $24.7M.
  • Armistice Capital added most to Hanesbrands in Q4 2017, an estimated $20.8M increase.
  • Armistice Capital's biggest Q4 2017 reduction was Madrigal Pharmaceuticals, cutting an estimated $8.68M.
  • Armistice Capital fully exited Regeneron Pharmaceuticals in Q4 2017, selling an estimated $22.4M.
  • Armistice Capital's ten largest holdings make up 46% of its $1B portfolio in Q4 2017.
  • Armistice Capital opened 30 new positions and closed 27 in Q4 2017.
  • Armistice Capital's portfolio value rose 18% quarter-over-quarter to $1B.

Based on Armistice Capital's 13F filing for Q4 2017, filed 14 Feb 2018.